| Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites Y Guo, CM Crnkovic, KJ Won, X Yang, JR Lee, J Orjala, H Lee, H Jeong Drug Metabolism and Disposition 47 (3), 194-202, 2019 | 113 | 2019 |
| Gut microbiota in reductive drug metabolism Y Guo, H Lee, H Jeong Progress in molecular biology and translational science 171, 61-93, 2020 | 43 | 2020 |
| Organic solvent-free, one-step engineering of graphene-based magnetic-responsive hybrids using design of experiment-driven mechanochemistry KC Mei, Y Guo, J Bai, PM Costa, H Kafa, A Protti, RC Hider, KT Al-Jamal ACS applied materials & interfaces 7 (26), 14176-14181, 2015 | 37 | 2015 |
| An integrated strategy for assessing the metabolic stability and biotransformation of macrocyclic peptides in drug discovery toward oral delivery Y Guo, S Ji, W Wang, S Wong, CW Yen, C Hu, DH Leung, E Plise, ... Analytical Chemistry 94 (4), 2032-2041, 2022 | 10 | 2022 |
| Blood profiles of gut bacterial tacrolimus metabolite in kidney transplant recipients Y Guo, H Lee, E Edusei, S Albakry, H Jeong, JR Lee Transplantation Direct 6 (10), e601, 2020 | 10 | 2020 |
| Determination of Acyl-, O-, and N-Glucuronide Using Chemical Derivatization Coupled with Liquid Chromatography–High-Resolution Mass Spectrometry Y Guo, A Shah, E Oh, SK Chowdhury, X Zhu Drug Metabolism and Disposition 50 (5), 716-724, 2022 | 5 | 2022 |
| The Role of Gut Bacteria in Tacrolimus Disposition Y Guo University of Illinois at Chicago, 2021 | 1 | 2021 |
| Structural differences in gut microbiota lead to altered hepatic expression of Drug Disposition Genes (DDG) in mice Y Guo, S Cho, E Chung, JS Park, H Jeong The FASEB Journal 31, 668.3-668.3, 2017 | | 2017 |
